These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7097254)

  • 1. An electron microscopic demonstration of immune complexes of hepatitis B e-antigen using colloid gold as a marker.
    Stannard LM; Lennon M; Hodgkiss M; Smuts H
    J Med Virol; 1982; 9(3):165-75. PubMed ID: 7097254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of rheumatoid factor in an electron microscope study of hepatitis B antigens.
    Stannard LM; Almeida JD; Tedder RS
    J Med Virol; 1980; 6(2):153-64. PubMed ID: 6264022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of HBeAg and anti-HBe among HBsAg carrier thai children.
    Pongpipat D; Suvatte V; Assateerawatts A
    J Med Assoc Thai; 1981 Nov; 64(11):562-7. PubMed ID: 7320671
    [No Abstract]   [Full Text] [Related]  

  • 4. [The interrelationships of hepatitis B e antigen antibody and HBsAg-circulating immune complexes in asymptomatic HBsAg carriers].
    Chang ML; Chou CT; Lee CF; Chang DM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):224-9. PubMed ID: 3256466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBeAg and anti-HBe in chronic hepatitis B virus infection.
    Chen DS; Sung JL; Lai MY
    Gastroenterology; 1981 Apr; 80(4):880-2. PubMed ID: 7202958
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan.
    Chen DS; Lai MY; Lee SC; Yang PM; Sheu JC; Sung JL
    J Med Virol; 1986 May; 19(1):87-94. PubMed ID: 3701304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
    Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
    Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the evolution of specific and non-specific immune complexes in acute hepatitis B and chronic hepatitis.
    Leyva A; Bernal MC; Piedrola G; Maroto MC
    J Med Microbiol; 1988 Jul; 26(3):237-9. PubMed ID: 3392730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity.
    Werner BG; Grady GF
    Ann Intern Med; 1982 Sep; 97(3):367-9. PubMed ID: 7114632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmatory evidence for the association of hepatitis B surface antigen with antigenic determinants reactive with antibodies present in some anti-HBe-positive sera.
    Neurath AR; Strick N; Huang CY
    J Gen Virol; 1980 May; 48(1):53-61. PubMed ID: 6155434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.
    Hoofnagle JH; Dusheiko GM; Seeff LB; Jones EA; Waggoner JG; Bales ZB
    Ann Intern Med; 1981 Jun; 94(6):744-8. PubMed ID: 7235415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of antibody to hepatitis Be antigen (anti-HBe) in HBsAg-negative individuals.
    Hess G; Arnold W; Gahl GM; Vogl E; Meyer zum Büschenfelde KH
    Vox Sang; 1981 Feb; 40(2):95-8. PubMed ID: 7233888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of hepatitis B e antigen (HBeAg) and anti-HBe in carriers with different levels of HBsAg.
    Nath N; Fang CT; Fields HA; Doto IL; Maynard JE
    J Med Virol; 1980; 6(2):179-84. PubMed ID: 7241093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-DNA, anti-HBc correlations with RIA-detected HBeAg and anti-HBe in chronic HBsAg carriers.
    Villarejos VM; Andersen-Visoná K; Serra J; Frösner GG; Deinhardt F
    J Med Virol; 1980; 5(4):265-71. PubMed ID: 7229619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaction spectrum of HBe antibodies.
    Babeş VT; Tănase M
    Virologie; 1981; 32(1):3-7. PubMed ID: 7303490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBeAg/anti-HBe circulating immune complexes in patients chronically infected with hepatitis B virus.
    Sansonno D; Vacca A; Gernone A; Dammacco F
    Ric Clin Lab; 1989; 19(1):81-91. PubMed ID: 2762731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the HBeAg/anti-HBe system in hepatitis B infection.
    Frösner GG
    Riv Emoter Immunoematol; 1980; 27(1-2):85-7. PubMed ID: 7466190
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating HBsAg/IgM complexes in acute and chronic hepatitis B.
    Musca A; Cordova C; Barnaba V; Zaccari C; Levrero M; van Dyke A; Balsano F
    Hepatogastroenterology; 1984 Oct; 31(5):208-10. PubMed ID: 6510881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBsAg subtypes among HBsAg carriers in Okinawa, Japan. Evidence of an important relationship in seroconversion from HBeAg to anti-HBe.
    Noguchi A; Hayashi J; Nakashima K; Hirata M; Ikematsu H; Kashiwagi S
    J Infect; 1994 Mar; 28(2):141-50. PubMed ID: 8034993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with type B hepatitis.
    Arnold W; Hess G; Kawakami H; Meyer zum Büschenfelde KH
    Klin Wochenschr; 1981 Jun; 59(12):679-83. PubMed ID: 7253542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.